Shimon Sakaguchi MD, PhD

Dr. Sakaguchi, M.D., Ph.D. Specially Appointed Professor (full time), Immunology Frontier Research Center, Osaka University, discovered regulatory T (Treg) cells, which compose five percent of T cells and are specialized for Immuno-suppression. He has been studying the molecular basis of the development of naturally occurring Treg cells, and also human Treg cells, in particular, analyzing anti-tumor immune responses against adult T-cell leukemia, shedding new light on cancer immunotherapy. He was elected as a member of the National Academy of Sciences in 2012 and was also selected as one of the “Highly Cited Researchers” by Thomson Reuters CO, USA. Recently, he was awarded Canada Gairdner International Award in 2015.